Boston Scientific (BSX) EBT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.02% |
| Dec 31, 2025 | 17.92% |
| Sep 30, 2025 | 43.74% |
| Jun 30, 2025 | 48.41% |
| Mar 31, 2025 | 105.44% |
| Dec 31, 2024 | 150.94% |
| Sep 30, 2024 | 49.03% |
| Jun 30, 2024 | 23.70% |
| Mar 31, 2024 | 5.88% |
| Dec 31, 2023 | 11.28% |
| Sep 30, 2023 | 5.99% |
| Jun 30, 2023 | 4.19% |
| Mar 31, 2023 | 6.57% |
| Dec 31, 2022 | 11.77% |
| Sep 30, 2022 | -4.54% |
| Jun 30, 2022 | 30.54% |
| Mar 31, 2022 | -12.55% |
| Dec 31, 2021 | 5.98% |
| Sep 30, 2021 | 13.45% |
| Jun 30, 2021 | 18.89% |
| Mar 31, 2021 | 7.35% |
| Dec 31, 2020 | 23.80% |
| Sep 30, 2020 | 9.16% |
| Jun 30, 2020 | -30.08% |
| Mar 31, 2020 | 19.45% |
| Dec 31, 2019 | 59.55% |
| Sep 30, 2019 | 97.87% |
| Jun 30, 2019 | 27.69% |
| Mar 31, 2019 | 25.64% |
| Dec 31, 2018 | 38.07% |
| Sep 30, 2018 | 68.04% |
| Jun 30, 2018 | 17.95% |
| Mar 31, 2018 | 23.04% |
| Dec 31, 2017 | 34.28% |
| Sep 30, 2017 | 19.78% |
| Jun 30, 2017 | 15.16% |
| Mar 31, 2017 | 19.92% |
| Dec 31, 2016 | -2.30% |
| Sep 30, 2016 | 18.28% |
| Jun 30, 2016 | -35.17% |
| Mar 31, 2016 | -3.54% |
| Dec 31, 2015 | -28.30% |
| Sep 30, 2015 | -33.57% |
| Jun 30, 2015 | -2.47% |
| Mar 31, 2015 | 49.64% |
| Dec 31, 2014 | 16.28% |
| Sep 30, 2014 | 15.64% |
| Jun 30, 2014 | -20.85% |
| Mar 31, 2014 | 28.51% |